tiprankstipranks
Trending News
More News >
Biofrontera AG (GB:0DOL)
:0DOL
UK Market

Biofrontera (0DOL) Financial Statements

Compare
0 Followers

Biofrontera Financial Overview

Biofrontera's market cap is currently €15.19M. The company's EPS TTM is €; its P/E ratio is 541.55; Biofrontera is scheduled to report earnings on May 28, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 20Dec 19Dec 18Dec 17
Income Statement
Total Revenue
Gross Profit$ 16.63M$ 26.40M$ 26.70M$ 16.66M$ 10.31M
Operating Income$ -22.68M$ -11.85M$ -23.87M$ -18.48M$ -13.93M
EBITDA$ -18.45M$ 3.90M$ -5.92M$ -16.73M$ -14.09M
Net Income$ -20.13M$ -4.29M$ -14.12M$ -8.88M$ -15.25M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 27.93M$ 56.39M$ 58.36M$ 39.13M$ 19.85M
Total Debt$ 5.40M$ 1.14M$ 1.21M$ 13.63M$ 12.53M
Net Debt$ 4.06M$ -15.41M$ -9.91M$ -6.62M$ 872.00K
Total Liabilities$ 23.14M$ 96.76M$ 93.26M$ 22.78M$ 16.47M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -24.91M$ -2.85M$ -32.89M$ -13.95M$ -13.52M
Operating Cash Flow$ -24.90M$ -2.85M$ -32.89M$ -13.43M$ -13.12M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Biofrontera Earnings and Revenue History

Biofrontera Debt to Assets

Biofrontera Cash Flow

Biofrontera Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis